This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
We recently became aware of the paper by Halprin KW et al, (Arch Derm 103:243-249, 1971), wherein the pharmacokinetics of methotrexate are described. They observed a rather short half-life (two to ten hours) for methotrexate following both oral and intramuscular administration.Based upon recent studies in our laboratory with use of tritium-labeled methotrexate, we wish to report that the plasma half-life for methotrexate in man is considerably longer than that reported. In 18 patients, the plasma disappearance of methotrexate is biphasic with the short half-life (representing drug distribution) of about one-half hour and the long plasma half-life (representing drug elimination) of 25 to 30 hours. The half-life value reported by Halprin et al most likely represents the distributive phase rather than the longer and more important half-life. In addition, we have examined the fluorometric method and find that its lower limit of sensitivity is 0.1μg/ml. Since it
Huffman DH, Wan SH, Azarnoff DL. Half-Life of Methotrexate: New Evidence. Arch Dermatol. 1972;105(5):761–762. doi:10.1001/archderm.1972.01620080083030
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.